Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stepanova

Showing results (691-700 of 1,968) with videos related to

Pageof 197
Sort By:
Entropy (Basel, Switzerland)|May 5, 2021
Multifractal Characteristics of Geomagnetic Field Fluctuations for the Northern and Southern Hemispheres at Swarm AltitudeBenjamín Toledo, Pablo Medina, Sylvain Blunier, et al.
Journal of Clinical and Experimental Hepatology|May 10, 2022
Health-Related Quality of Life and Health Care Resource Utilization in Patients With Chronic Liver Disease and Primary Liver Cancer in the United States: Analysis of Medical Expenditure Panel SurveyIssah Younossi, Maria Stepanova, Mercedes Walters, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 5, 2017
Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 studyZobair M Younossi, Maria Stepanova, Mark Sulkowski, et al.
Frontiers in Immunology|June 4, 2019
Perturbation of Thymocyte Development Underlies the PRRS Pandemic: A Testable HypothesisJohn E Butler, Marek Sinkora, Gang Wang, et al.
Journal of Translational Medicine|February 9, 2012
The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirinZobair M Younossi, Aybike Birerdinc, Mike Estep, et al.
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|April 1, 1992
Monoclonal antibody to alkaline phosphatase from the intestinal mucosa of the harp seal, Phoca groenlandicaSakharov IYu, E B Mechetner, I E Stepanova, et al.
Alimentary Pharmacology & Therapeutics|July 22, 2014
Patients' preferences and health utility assessment with SF-6D and EQ-5D in patients with chronic hepatitis C treated with sofosbuvir regimensM Stepanova, F Nader, S Cure, et al.
Alimentary Pharmacology & Therapeutics|September 14, 2013
The impact of chronic hepatitis C on resource utilisation and in-patient mortality for Medicare beneficiaries between 2005 and 2010Z M Younossi, M Stepanova, A Mishra, et al.
Journal of Clinical Gastroenterology|March 19, 2014
Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver diseaseZobair M Younossi, Li Zheng, Maria Stepanova, et al.
Clinical Transplantation|October 15, 2016
Long-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registryMaria Stepanova, Trevor Locklear, Nila Rafiq, et al.
Pageof 197

Showing results (691-700 of 1,968) with videos related to

Sort By:
Pageof 197
Entropy (Basel, Switzerland)|May 5, 2021
Multifractal Characteristics of Geomagnetic Field Fluctuations for the Northern and Southern Hemispheres at Swarm AltitudeBenjamín Toledo, Pablo Medina, Sylvain Blunier, et al.
Journal of Clinical and Experimental Hepatology|May 10, 2022
Health-Related Quality of Life and Health Care Resource Utilization in Patients With Chronic Liver Disease and Primary Liver Cancer in the United States: Analysis of Medical Expenditure Panel SurveyIssah Younossi, Maria Stepanova, Mercedes Walters, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 5, 2017
Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 studyZobair M Younossi, Maria Stepanova, Mark Sulkowski, et al.
Frontiers in Immunology|June 4, 2019
Perturbation of Thymocyte Development Underlies the PRRS Pandemic: A Testable HypothesisJohn E Butler, Marek Sinkora, Gang Wang, et al.
Journal of Translational Medicine|February 9, 2012
The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirinZobair M Younossi, Aybike Birerdinc, Mike Estep, et al.
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|April 1, 1992
Monoclonal antibody to alkaline phosphatase from the intestinal mucosa of the harp seal, Phoca groenlandicaSakharov IYu, E B Mechetner, I E Stepanova, et al.
Alimentary Pharmacology & Therapeutics|July 22, 2014
Patients' preferences and health utility assessment with SF-6D and EQ-5D in patients with chronic hepatitis C treated with sofosbuvir regimensM Stepanova, F Nader, S Cure, et al.
Alimentary Pharmacology & Therapeutics|September 14, 2013
The impact of chronic hepatitis C on resource utilisation and in-patient mortality for Medicare beneficiaries between 2005 and 2010Z M Younossi, M Stepanova, A Mishra, et al.
Journal of Clinical Gastroenterology|March 19, 2014
Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver diseaseZobair M Younossi, Li Zheng, Maria Stepanova, et al.
Clinical Transplantation|October 15, 2016
Long-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registryMaria Stepanova, Trevor Locklear, Nila Rafiq, et al.
Pageof 197